There are errors present in the values presented in Table 5. Table 5 shows the observed probability. The corrected version of Table 5 now shows the estimated probability. The development and validation of the models is presented in Tables 2–4 and Figs 1–2 and these aspects of the work stand unaffected. The final "tool" that clinicians would be using is Table 5 to show the predicted probability that their patient with a given score will develop diabetes over the next 3 years. This is the culmination of the modeling work and has been reported incorrectly in the original publication. Please see the corrected Table 5 here.
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Table 5. Total point for each risk score and absolute estimated probability (%) of incidence of type 2 diabetes.
https://doi.org/10.1371/journal.pone.0199075.t001
The twenty-sixth author’s name appears incorrectly. The correct name is: Huanhuan Hu.
There are several text errors throughout the article. The errors and corrections are as follows:
The last line of the Results paragraph of the Abstract section should read: Participants with a noninvasive score of ≥15 and invasive score of ≥ 18 were projected to have >20% and >50% risk, respectively, of developing type 2 diabetes within 3 years.
The last two lines of the sixth paragraph of the Results section should read: In the invasive model including both FPG and HbA1c, participants with a score of 0 to 10 (77.4% of total participants), 11 to 12 (10.5%), 13 to 14 (6.9%), and 15 to 17 (5.0%) had less than 5%, 5 to <10%, 10 to <20%, and 20 to <50% risk of incident type 2 diabetes, respectively. Those with a score of ≥18 (0.2% of total participants) had >50% risk.
There are errors in the figure caption for Fig 1. Please see the correct Fig 1 caption here.
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 1. Receiver operating characteristics (ROC) curves for each risk score model in predicting type 2 diabetes.
Abbreviation: FPG, fasting plasma glucose. In the derivation cohort, the area under the ROC (95% confidence interval) were 0.717 (0.703–0.731) for the non-invasive model, 0.843 (0.832–0.853) for the model including FPG, 0.827 (0.816–0.838) for the model including HbA1c, and 0.893 (0.883–0.902) for the model including both FPG and HbA1c. In the validation cohort, the corresponding value were 0.734 (0.715–0.753) for the non-invasive model, 0.835 (0.820–0.851) for the model including FPG, 0.819 (0.803–0.835) for the model including HbA1c, and 0.882 (0.868–0.895) for the model including both FPG and HbA1c.
https://doi.org/10.1371/journal.pone.0199075.g001
1. Nanri A, Nakagawa T, Kuwahara K, Yamamoto S, Honda T, Okazaki H, et al. (2015) Development of Risk Score for Predicting 3-Year Incidence of Type 2 Diabetes: Japan Epidemiology Collaboration on Occupational Health Study. PLoS ONE 10(11): e0142779. https://doi.org/10.1371/journal.pone.0142779 pmid:26558900
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2018 Nanri et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.